Screening adsorbents for the prevention of drug-induced intestinal dysbiosis at pre-formulation stage: case example activated charcoal
Abstract
OBJECTIVES
Develop a biorelevant in vitro methodology to screen adsorbents for their safety and for their efficacy to remove unabsorbed drugs from the colonic lumen using activated charcoal (AC) as a model adsorbent; Evaluate AC's usefulness in preventing drug-induced intestinal dysbiosis based on in vitro data.
METHODS
Published clinical data with AC and moxifloxacin were used to evaluate biorelevance of the in vitro methodology. In vitro data with four drugs were used to evaluate the usefulness of AC in preventing drug-induced intestinal dysbiosis.
KEY FINDINGS
In line with human data, in vitro data indicated that AC has no impact on osmolality and bacterial enzyme activity, and that complete removal of moxifloxacin accumulating in the colon after daily dosing requires the dispersion of >7 g Filtercarb Pharma-A to the colonic lumen. In vitro data with rosuvastatin, azithromycin, and metformin indicated that complete removal after daily dosing requires the dispersion of >3 g, ≈25 g, and >45 g Filtercarb Pharma-A, respectively, to the colonic lumen.
CONCLUSIONS
An in vitro methodology to screen adsorbents for their safety and for their efficacy in removing unabsorbed drugs from the colonic lumen was developed. The effectiveness of AC may be limited by the size and the performance variability of the colon-targeting product.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.